Literature DB >> 34245754

Smartphone Use Associated with Refractive Error in Teenagers: The Myopia App Study.

Clair A Enthoven1, Jan Roelof Polling2, Timo Verzijden3, J Willem L Tideman3, Nora Al-Jaffar3, Pauline W Jansen4, Hein Raat5, Lauwerens Metz6, Virginie J M Verhoeven7, Caroline C W Klaver8.   

Abstract

PURPOSE: To investigate the association between smartphone use and refractive error in teenagers using the Myopia app.
DESIGN: Cross-sectional population-based study. PARTICIPANTS: A total of 525 teenagers 12 to 16 years of age from 6 secondary schools and from the birth cohort study Generation R participated.
METHODS: A smartphone application (Myopia app; Innovattic) was designed to measure smartphone use and face-to-screen distance objectively and to pose questions about outdoor exposure. Participants underwent cycloplegic refractive error and ocular biometry measurements. Mean daily smartphone use was calculated in hours per day and continuous use as the number of episodes of 20 minutes on screen without breaks. Linear mixed models were conducted with smartphone use, continuous use, and face-to-screen distance as determinants and spherical equivalent of refraction (SER) and axial length-to-corneal radius (AL:CR) ratio as outcome measures stratified by median outdoor exposure. MAIN OUTCOME MEASURES: Spherical equivalent of refraction in diopters and AL:CR ratio.
RESULTS: The teenagers on average were 13.7 ± 0.85 years of age, and myopia prevalence was 18.9%. During school days, total smartphone use on average was 3.71 ± 1.70 hours/day and was associated only borderline significantly with AL:CR ratio (β = 0.008; 95% confidence interval [CI], -0.001 to 0.017) and not with SER. Continuous use on average was 6.42 ± 4.36 episodes of 20-minute use without breaks per day and was associated significantly with SER and AL:CR ratio (β = -0.07 [95% CI, -0.13 to -0.01] and β = 0.004 [95% CI, 0.001-0.008], respectively). When stratifying for outdoor exposure, continuous use remained significant only for teenagers with low exposure (β = -0.10 [95% CI, -0.20 to -0.01] and β = 0.007 [95% CI, 0.001-0.013] for SER and AL:CR ratio, respectively). Smartphone use during weekends was not associated significantly with SER and AL:CR ratio, nor was face-to-screen distance.
CONCLUSIONS: Dutch teenagers spent almost 4 hours per day on their smartphones. Episodes of 20 minutes of continuous use were associated with more myopic refractive errors, particularly in those with low outdoor exposure. This study suggested that frequent breaks should become a recommendation for smartphone use in teenagers. Future large longitudinal studies will allow more detailed information on safe screen use in youth.
Copyright © 2021 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Myopia; Outdoor exposure; Refractive error; Smartphone use; Teenagers

Mesh:

Year:  2021        PMID: 34245754     DOI: 10.1016/j.ophtha.2021.06.016

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  4 in total

1.  A Latent Class Analysis of Student Eye Care Behavior: Evidence From a Sample of 6-17 Years Old in China.

Authors:  Mengying Li; Wenjing Wang; Boya Zhu; Xiaodong Tan
Journal:  Front Public Health       Date:  2022-06-15

2.  Editorial: Advances in the Pathophysiology, Diagnosis, and Treatment of Dry Eye Disease.

Authors:  Yiteng Lu; Yuqing Wu; Xujiao Zhou; Takenori Inomata; Lei Gu; Xiuming Jin; Jiaxu Hong
Journal:  Front Med (Lausanne)       Date:  2022-05-19

3.  A multicenter Spanish study of atropine 0.01% in childhood myopia progression.

Authors:  Inés Pérez-Flores; Beatríz Macías-Murelaga; Jesús Barrio-Barrio
Journal:  Sci Rep       Date:  2021-11-05       Impact factor: 4.379

4.  The associations between problematic smartphone use and blood pressure among 2,573 aged 9-17 years students in Shanghai, China.

Authors:  Shaojie Liu; Yukun Lan; Gengsheng He; Bo Chen; Yingnan Jia
Journal:  Front Public Health       Date:  2022-09-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.